NDV-HXP-S

AXP000209.1 · Vaccine

Platform
Newcastle disease virus (LaSota) vector
Targets
SARS-CoV-2 S
Originator
Icahn School of Medicine at Mount Sinai
Sponsor
Laboratorio Avi-Mex (Avimex)

Names

NameTypeSource
NDV-HXP-Spreferred name, codecurator, paper
Patriabrandpress
ButanVac ambiguoussynonymcurator
HXP-GPOVac ambiguoussynonymcurator

Virus

Role
Vaccine vector
Family
Paramyxoviridae
Virus
Newcastle disease virus (NCBI Taxonomy 2560319)
Strain
LaSota
Replication
replicating
Modifications
SARS-CoV-2 spike ectodomain with six stabilising proline mutations (HexaPro) and a deleted polybasic cleavage site, fused to the NDV fusion protein transmembrane and cytoplasmic domains
Transgenes
SARS-CoV-2 spike (HexaPro)
Route
intramuscular, intranasal
Source
evidence

Approvals

AgencyRegionDateStatusBrandIndicationSource
otherMX2024-06conditionalPatriaEmergency-use authorisation as a COVID-19 vaccinesource

Clinical trials (6)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT07215520Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated AdultsActive not recruitingPhase 22025-11-032026-09-06200COVID-19
NCT05354024Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) VaccineCompletedPhase 2/32023-02-282023-10-054400Coronavirus Infections; Healthy
NCT05181709A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.CompletedPhase 12022-02-092023-05-0335SARS-CoV-2
NCT05940194NDV-HXP-S Vaccine Clinical Trial (COVIVAC)CompletedPhase 22021-08-112021-10-18374COVID-19
NCT04993209Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in BrazilCompletedPhase 12021-07-092021-12-10320Coronavirus Infections; Healthy
NCT04764422Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in ThailandCompletedPhase 1/22021-03-202022-09-12455Covid-19; Covid-19 Vaccine; Pneumonia, Viral; SARS Pneumonia

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 42378814Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults.Vaccine2026cited by trial NCT05181709
PMID 39527880Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 "Patria" recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico.Vaccine2025name in title: Patria
PMID 39615342Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial.Vaccine2025cited by trial NCT05940194
PMID 39667115A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge.Vaccine2025cited by trial NCT05181709
PMID 40037239Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil.Vaccine2025cited by trial NCT04993209
PMID 36435633Nasal vaccines: solutions for respiratory infectious diseases.Trends in molecular medicine2023cited by trial NCT05354024
PMID 35284808Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial.EClinicalMedicine2022cited by trial NCT04764422
PMID 35577631Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.Vaccine2022name in abstract: NDV-HXP-S
PMID 34580673Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial.medRxiv : the preprint server for health sciences2021cited by trial NCT04764422
Unconfirmed matches (1)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 42869875Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 μg HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIA.Vaccine2026name in title: HXP-GPOVac

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 41288394Development of an RT-qPCR and a Next-Generation Sequencing approach to assess viral shedding of NDV-based SARS-CoV-2 variant vaccines.Microbiology spectrum2026name in abstract: NDV-HXP-S
PMID 41746060AddaVax, AddaS03, and Alum Effectively Enhance Cross-Reactive and Cross-Neutralizing Antibody Responses Against SARS-CoV-2 Induced by the Inactivated NDV-HXP-S Vaccine in Mice.Vaccines2026name in title: NDV-HXP-S
PMID 41926837COVID-19 in Latin America: Clinical and immunological insights, vaccine development, and lessons for pandemic preparedness.Seminars in immunology2026name in abstract: Patria
PMID 42347602Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.Vaccines2026name in title: NDV-HXP-S
PMID 42646679Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults.Vaccines2026name in title: NDV-HXP-S
PMID 42943471Systemic T-Cell Activation Landscapes Elicited Following Intramuscular and Intranasal Immunization with the Active NDV-Vectored Anti-COVID-19 Vaccine "Patria" in Humans.Microorganisms2026name in title: Patria
PMID 42955440Environmental monitoring of the Lagoon of Lake Patria in South Tyrrhenian sea, Italy.Environmental monitoring and assessment2026name in title: Patria
PMID 40165947Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models.Frontiers in immunology2025name in abstract: NDV-HXP-S
PMID 40241155Navigating authoritarian politics: towards reflexive framing in healthcare research.Globalization and health2025name in abstract: Patria
PMID 40458417Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 'Patria' vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version.Frontiers in immunology2025name in title: Patria
PMID 40789265Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S).Vaccine2025name in title: NDV-HXP-S
PMID 41271759Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters.NPJ vaccines2025name in abstract: NDV-HXP-S
PMID 41290704One year follow up of phase 1/2 randomized, placebo controlled trial of NDV-HXP-S vaccine in Thailand.NPJ vaccines2025name in title: NDV-HXP-S
PMID 38369699Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine.Expert review of vaccines2024name in abstract: NDV-HXP-S
PMID 38372198Development of a quantitative ELISA for SARS-CoV-2 vaccine candidate, NDV-HXP-S, with CpG 1018® adjuvant.Human vaccines & immunotherapeutics2024name in title: NDV-HXP-S
PMID 38848648Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice.EBioMedicine2024name in abstract: NDV-HXP-S
PMID 39189025Development of multidose thermotolerant formulations of a vector-based Covid-19 vaccine candidate, NDV-HXP-S in different product formats: Stability and preservative efficacy study.Vaccine: X2024name in title: NDV-HXP-S
PMID 36791207An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination.Science translational medicine2023name in title: NDV-HXP-S
PMID 37164959Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico.NPJ vaccines2023name in abstract: NDV-HXP-S
PMID 34520260"Un abrazo a la distancia": An Exploration of Spanish-Speaking Women's Experiences with Pregnancy and Social Isolation in an Urban U.S. Setting.Hispanic health care international : the official journal of the National Association of Hispanic Nurses2022name in abstract: Patria
PMID 35169806Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico.medRxiv : the preprint server for health sciences2022name in title: Patria
PMID 35263331Prevalence rate and risk factors of human cystic echinococcosis: A cross-sectional, community-based, abdominal ultrasound study in rural and urban north-central Chile.PLoS neglected tropical diseases2022name in abstract: Patria
PMID 35350201Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice.bioRxiv : the preprint server for biology2022name in title: NDV-HXP-S
PMID 35658571Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice.Microbiology spectrum2022name in title: NDV-HXP-S
PMID 33903511Notes on some Tanzanian butterfly specimens in the Suffert Collection: a case of patria/ falsa/.Zootaxa2021name in title: Patria
PMID 34544278Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs.mBio2021name in title: Patria
PMID 34707161A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses.Nature communications2021name in abstract: NDV-HXP-S
PMID 34868082Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.Frontiers in immunology2021name in title: NDV-HXP-S
PMID 33399661[Epidemiology of Chagas disease: high mortality and incidence rate, Coquimbo Region].Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia2020name in abstract: Patria
PMID 31460517Prof. Dr. Gheorghe Bilaşcu. Pro patria.Medicine and pharmacy reports2019name in title: Patria
PMID 28943445The effects of Cissampelos pareira extract on envenomation induced by Bothropsdiporus snake venom.Journal of ethnopharmacology2018name in abstract: Patria
PMID 28898336[Analysis of human cyst echinococcosis in a northern Chilean region from 2008 to 2012].Revista medica de Chile2017name in abstract: Patria
PMID 29245600On the identity of Photophilus Folkmanová, 1928: A new generic synonymy (Chilopoda: Geophilomorpha: Geophilidae).Zootaxa2017name in abstract: Patria
PMID 27346542Wnt, Frizzled, and sFRP gene expression patterns during gastrulation in the starfish Patiria (Asterina) pectinifera.Gene expression patterns : GEP2016name in abstract: Patria
PMID 26701539True identity of Folkmanovius paralellus Dobroruka (Chilopoda: Geophilomorpha: Geophilidae).Zootaxa2015name in abstract: Patria
PMID 22507409Pro patria et spes gentis: military medicine, paediatric surgery and those who care for children.ANZ journal of surgery2011name in title: Patria
PMID 19172493Outpatient or inpatient stem cell transplantation: patria est ubicunque est bene?Leukemia & lymphoma2009name in title: Patria
PMID 18952529[Assumption of medical risks and the problem of medical liability in ancient Roman law].Orvosi hetilap2008name in abstract: Patria
PMID 17242608Nontherapeutic quality improvement: The conflict of organizational ethics and societal rule of law.Critical care medicine2007name in abstract: Patria
PMID 17967498Probabilistic risk assessment for linear alkylbenzene sulfonate (LAS) in sewage sludge used on agricultural soil.Regulatory toxicology and pharmacology : RTP2007name in abstract: Patria
PMID 19522096Children of the patria: representations of childhood and welfare state ideologies at the 1922 Rio de Janeiro International Centennial Exposition.Americas (Academy of American Franciscan History)2001name in title: Patria
PMID 2641957[Dental caries in preschoolers and students in Monte Patria, region 4].Odontologia chilena1989name in title: Patria
PMID 17269197New light on the patria of Arnald of Villanova.Viator1982name in title: Patria
PMID 7189137Electron microscopic study of the cortical reaction in eggs of the starfish (Patria miniata).Cell and tissue research1980name in title: Patria
PMID 5436268[Patria potestas and medical interventions affecting minor children].Minerva pediatrica1970name in title: Patria
PMID 14275616[THE "L. PATRIA" GERIATRIC INSTITUTE OF ALEXANDRIA. CONTRIBUTION TO THE SOLUTION OF A SOCIAL PROBLEM].Giornale di gerontologia1964name in title: Patria

Notes

Live recombinant NDV-LaSota displaying a HexaPro prefusion-stabilised SARS-CoV-2 spike anchored by the NDV F transmembrane and cytoplasmic domains. Authorised for emergency use in Mexico as Patria (COFEPRIS, June 2024). The same construct is made under licence by other manufacturers (ButanVac in Brazil, HXP-GPOVac in Thailand); treated as one program per SPEC section 1 and those names are flagged ambiguous. Avimex also developed an inactivated presentation; the clinical trials cited here used the live vaccine.

How to cite

NDV-HXP-S (AXP000209.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000209.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.